Pcyc-1128-Ca
ClinicalTrials.gov NCT02599324
Research payments
$700,658
Through program year 2020, $700,658 in research payments was reported against Pcyc-1128-Ca, across 103 payments, paid by Pharmacyclics LLC, An AbbVie Company.
- Paid by
- Pharmacyclics LLC, An AbbVie Company
- ClinicalTrials.gov
- NCT02599324
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $700,658 | 103 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Yousef Zakharia Iowa City, IA Named on 15 payments
- Nataliya Mar Orange, CA Named on 9 payments
- Lindsay Overton Wenatchee, WA Named on 7 payments
- Alexander Spira Reston, VA Named on 6 payments
- Michael Pishvaian Washington, DC Named on 6 payments
- Surrinder Dang Huntsville, AL Named on 6 payments
- Elisabeth Heath Detroit, MI Named on 6 payments
- David Quinn Los Angeles, CA Named on 5 payments
- Nelson Yee Hershey, PA Named on 4 payments
- Jordan Berlin Nashville, TN Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.